NCT06722456View on ClinicalTrials.gov

Assessment of Non-invasive Tools for Detecting Active Inflammatory Bowel Disease

Enrolling by invitationOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 15, 2025

Conditions
Inflammatory Bowel Disease (IBD)Crohn Disease (CD)Ulcerative Colitis (UC)
Interventions
DIAGNOSTIC_TEST

Analysis of protein signatures in stool samples

Stool protein signatures are to be established in parallel to standard clinical evaluation of the intestinal inflammatory activity.

Trial Locations (1)

J1H 5N4

Centre de recherche of the CIUSSS de l'Estrie-CHUS, Sherbrooke

All Listed Sponsors
lead

Jean-François Beaulieu

OTHER